Supplements Used For Autism Do Not Need Overt Claims To Draw Scrutiny
This article was originally published in The Tan Sheet
Executive Summary
Marketers of dietary supplements used in patients with autistic spectrum disorders must contend with watchful federal regulators and controversies surrounding the conditions' causes
You may also be interested in...
FDA Chelation Warnings Reflect Growth In Bogus OTCs, Supplements
FDA says its Oct. 14 warnings about unapproved autism treatment claims for chelation products marketed as OTCs or dietary supplements reflect a growing problem of fraud in consumer health care product marketing
FDA Chelation Warnings Reflect Growth In Bogus OTCs, Supplements
FDA says its Oct. 14 warnings about unapproved autism treatment claims for chelation products marketed as OTCs or dietary supplements reflect a growing problem of fraud in consumer health care product marketing
FDA Chelation Warnings Reflect Growth In Bogus OTCs, Supplements
FDA says its Oct. 14 warnings about unapproved autism treatment claims for chelation products marketed as OTCs or dietary supplements reflect a growing problem of fraud in consumer health care product marketing